Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Acute

Showing NaN - NaN of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Oral Azacitidine
  • Placebo
  • Phoenix, Arizona
  • +247 more
Jan 13, 2023

Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

Active, not recruiting
Has Results
  • Myelodysplastic Syndrome
  • +2 more
  • Daphne, Alabama
  • +241 more
Dec 23, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +23 more
Aug 1, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)

    Terminated
    • Leukemia, Myeloid, Acute
    • NLA101
    • Standard of Care (SOC) chemotherapy
    • La Jolla, California
    • +35 more
    Mar 25, 2021

    Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • SGI-110 (guadecitabine)
    • Treatment Choice
    • Scottsdale, Arizona
    • +134 more
    Dec 21, 2020

    Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • Los Angeles, California
    • +23 more
    Dec 20, 2019

    Leukemia, Myeloid, Acute Trial in United States (AC220, daunorubicin, cytarabine)

    Completed
    • Leukemia, Myeloid, Acute
    • Jacksonville, Florida
    • +4 more
    Feb 8, 2019

    Leukemia, Myeloid, Acute Trial in United States (AC220)

    Completed
    • Leukemia, Myeloid, Acute
    • Duarte, California
    • +4 more
    Feb 8, 2019

    Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)

    Terminated
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Phoenix, Arizona
    • +5 more
    Oct 17, 2018

    Leukemia, Myeloid, Acute Trial in United States (BI 836858)

    Completed
    • Leukemia, Myeloid, Acute
    • BI 836858
    • Chicago, Illinois
    • +4 more
    May 22, 2018

    Leukemia, Myeloid, Acute, Hematologic Tumors Trial in France, United States (Pimasertib)

    Terminated
    Has Results
    • Leukemia, Myeloid, Acute
    • Hematologic Neoplasms
    • Chicago, Illinois
    • +8 more
    Jul 19, 2017

    Leukemia, Myeloid, Acute Trial in Australia, United States (CSL362)

    Completed
    • Leukemia, Myeloid, Acute
    • CSL362
    • Chicago, Illinois
    • +4 more
    Oct 8, 2015

    Leukemia, Myeloid, Acute Trial in United States (Troxatyl™ (troxacitabine))

    Terminated
    • Leukemia, Myeloid, Acute
    • Troxatyl™ (troxacitabine)
    • LaJolla, California
    • +19 more
    Nov 1, 2006